In this episode, guests Tommy Axford and Dr. Natalya Gertsik from Private Health Management (PHM), talk about clinical trials and cancer care. They discuss why employers struggle with cancer-related costs and how clinical trials can be both medically beneficial and cost-effective. The conversation centers on the unique challenges cancer presents as a complex set of diseases rather than a single condition with standard solutions. Dr. Gertsik highlights a story about "Peter," who was given three months to live but achieved complete remission through a clinical trial identified by PHM. As Peter recounts, "It has now been a dozen years that I have been in remission from what was an original death sentence."
The discussion explores barriers to clinical trial access, including the vast number of trials available and various patient, provider, and institutional challenges. With specialty oncology medications averaging $65,000, clinical trials sponsored by pharmaceutical companies can offer significant cost savings for employers. Dr. Gertsik, "Most of the benefits employers are putting in place work for 95 percent of their population, but they don't work as well for the sickest and most expensive 5%."
Key Takeaways:
Stay in Touch!
Connect with our co-hosts Brittany Hardaway and David Pittman
Have feedback, questions, or suggestions for show ideas? Send them to us at podcast@springbuk.com.
Please rate and review us on your favorite podcast platform, and share it with your friends and colleagues. We appreciate you and thank you for listening!
Produced by David Pittman
Theme music: "Overboard" by Stay Outside